Ximelagatran sets the stage for NOACs
Author:
- 14 December 2017
- journal article
- Published by Springer Nature in Nature Reviews Cardiology
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor XimelagatranNew England Journal of Medicine, 2003
- Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee ReplacementNew England Journal of Medicine, 2003
- A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE IJournal of Thrombosis and Haemostasis, 2003